Not Signed In -
Water-Related Injuries |
|
|
Clinical Trial: Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20
This study is no longer recruiting patients.
Purpose
The purpose of this study is to assess the degree in which opioid-dependent outpatients discount the value of an additional maintenance dose of buprenorphine under differing states of opioid deprivation.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Opioid-Related Disorders | Drug: Buprenorphine | Phase II |
MedlinePlus related topics: Drug Abuse
Study Type: Interventional
Study Design: Treatment, Uncontrolled
Official Title: Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients
Further Study Details:
Study start: August 1997
Eligibility
Ages Eligible for Study: 18 Years - 47 Years, Genders Eligible for Study: Both
Criteria
Please contact site for information.
Location Information
Vermont
Treatment Research Center, Burlington, Vermont, 05401, United States
Study chairs or principal investigators
Warren Bickel, Ph.D., Principal Investigator, University of Vermont
More Information
Study ID Numbers: NIDA-06969-20; R01-06969-20
Record last reviewed: August 1997
Last Updated: November 18, 2004
Record first received: September 20, 1999
ClinicalTrials.gov Identifier: NCT00000238
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: August 1997
Last Updated: November 18, 2004
Record first received: September 20, 1999
ClinicalTrials.gov Identifier: NCT00000238
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
email this page
print this page
bookmark this page
feedback on this page
